X
EW icon

Xponance’s Edwards Lifesciences EW Stock Holding History

Xponance’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.3M Sell
102,830
-2,208
-2% -$185K 0.06% 256
2026
Q1 		$8.41M Buy
105,038
+16,908
+19% +$1.39M 0.06% 248
2025
Q4 		$7.51M Buy
88,130
+5,005
+6% +$411K 0.06% 250
2025
Q3 		$6.46M Sell
83,125
-3,659
-4% -$286K 0.05% 276
2025
Q2 		$6.79M Sell
86,784
-7,934
-8% -$592K 0.06% 261
2025
Q1 		$6.87M Sell
94,718
-370
-0.4% -$26.5K 0.07% 239
2024
Q4 		$7.04M Buy
95,088
+1,675
+2% +$117K 0.06% 232
2024
Q3 		$6.16M Buy
93,413
+1,120
+1% +$81.4K 0.06% 250
2024
Q2 		$8.53M Sell
92,293
-46,106
-33% -$4.08M 0.09% 175
2024
Q1 		$13.2M Sell
138,399
-578
-0.4% -$48.6K 0.14% 127
2023
Q4 		$10.6M Sell
138,977
-2,186
-2% -$152K 0.13% 135
2023
Q3 		$9.78M Buy
141,163
+2,273
+2% +$183K 0.13% 131
2023
Q2 		$13.1M Sell
138,890
-387
-0.3% -$33.6K 0.17% 101
2023
Q1 		$11.5M Buy
139,277
+2,379
+2% +$187K 0.17% 114
2022
Q4 		$10.2M Buy
136,898
+9,334
+7% +$719K 0.17% 117
2022
Q3 		$10.5M Buy
127,564
+2,265
+2% +$218K 0.2% 93
2022
Q2 		$11.9M Sell
125,299
-10,586
-8% -$1.1M 0.24% 72
2022
Q1 		$16M Buy
135,885
+1,395
+1% +$156K 0.27% 70
2021
Q4 		$17.4M Buy
134,490
+9,052
+7% +$1.06M 0.27% 63
2021
Q3 		$14.2M Sell
125,438
-2,995
-2% -$342K 0.27% 71
2021
Q2 		$13.3M Sell
128,433
-4,270
-3% -$402K 0.24% 72
2021
Q1 		$11.1M Buy
132,703
+41,596
+46% +$3.52M 0.24% 79
2020
Q4 		$8.31M Sell
91,107
-39,682
-30% -$3.29M 0.18% 100
2020
Q3 		$10.4M Sell
130,789
-8,509
-6% -$664K 0.26% 73
2020
Q2 		$9.63M Buy
+139,298
New +$9.9M 0.25% 85

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Xponance's EW Position: Q2 2026 in Review

Xponance reduced its Edwards Lifesciences (EW) stake by 2.1% in Q2 2026, selling an estimated $185K and leaving 102,830 shares worth $9.3M. The position accounts for 0.06% of the portfolio, ranked #256.

Xponance first reported a position in EW in Q2 2020 and has held it in 25 quarters since. The position peaked at $17.4M in Q4 2021. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Xponance held 102,830 shares of Edwards Lifesciences worth $9.3M as of Q2 2026.
  • Xponance sold 2,208 Edwards Lifesciences shares in Q2 2026, an estimated $185K.
  • Edwards Lifesciences made up 0.06% of Xponance's portfolio in Q2 2026, its #256 holding.
  • Xponance first reported a position in Edwards Lifesciences in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Edwards Lifesciences position peaked at $17.4M in Q4 2021.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.